Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue

British Journal of Cancer

Volumn 108, Issue 3, 2013, Pages 638-643

  Kauppila, J H ^a,b   Mattila, A E ^a,b   Karttunen, T J ^a,b   Salo, T ^a,b,c  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TOLL LIKE RECEPTOR 5;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER TISSUE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; MOUTH SQUAMOUS CELL CARCINOMA; ORAL TONGUE SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RISK FACTOR; SEX DIFFERENCE; TONGUE; TONGUE CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TOLL-LIKE RECEPTOR 5; TONGUE; TONGUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84875222510     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.589     Document Type: Article

References (34)

1. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499-511.
2. Bello IO, Vered M, Dayan D, Dobriyan A, Yahalom R, Alanen K, Nieminen P, Kantola S, Laara E, Salo T (2011) Cancer-associated fibroblasts, a parameter of the tumor microenvironment, overcomes carcinomaassociated parameters in the prognosis of patients with mobile tongue cancer. Oral Oncol 47: 33-38.
3. Bonnardot L, Bardet E, Steichen O, Cassagnau E, Piot B, Salam AP, Campion L, Ferron C, Beauvillain de Montreuil C, Malard O (2011) Prognostic factors for T1-T2 squamous cell carcinomas of the mobile tongue: a retrospective cohort study. Head Neck 33: 928-934.
4. Cai Z, Sanchez A, Shi Z, Zhang T, Liu M, Zhang D (2011) Activation of Tolllike receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth. Cancer Res 71: 2466-2475.
5. Dahlgren L, Dahlstrand HM, Lindquist D, Hogmo A, Bjornestal L, Lindholm J, Lundberg B, Dalianis T, Munck-Wikland E (2004) Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer 112: 1015-1019.
6. Gillison ML (2007) Current topics in the epidemiology of oral cavity and oropharyngeal cancers. Head Neck 29: 779-792.
7. Harris SL, Thorne LB, Seaman WT, Hayes DN, Couch ME, Kimple RJ (2011) Association of p16(INK4a) overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue. Head Neck 33: 1622-1627.
8. Jukkola-Vuorinen A, Rahko E, Vuopala KS, Desmond R, Lehenkari PP, Harris KW, Selander KS (2008) Toll-like receptor-9 expression is inversely correlated with estrogen receptor status in breast cancer. J Innate Immun 1: 59-68.
9. Kauppila JH, Takala H, Selander KS, Lehenkari PP, Saarnio J, Karttunen TJ (2011) Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma. Histopathology 59: 643-649.
10. Kim KY, Li S, Cha JD, Zhang X, Cha IH (2011) Significance of molecular markers in survival prediction of oral squamous cell carcinoma. Head Neck 34: 929-936.
11. Kim WY, Lee JW, Choi JJ, Choi CH, Kim TJ, Kim BG, Song SY, Bae DS (2008) Increased expression of Toll-like receptor 5 during progression of cervical neoplasia. Int J Gynecol Cancer 18: 300-305.
12. Kutikhin AG (2011) Association of polymorphisms in TLR genes and in genes of the Toll-like receptor signaling pathway with cancer risk. Hum Immunol 72: 1095-1116.
13. Li M, Zhou Y, Feng G, Su SB (2009) The critical role of Toll-like receptor signaling pathways in the induction and progression of autoimmune diseases. Curr Mol Med 9: 365-374.
14. Mager DL, Haffajee AD, Devlin PM, Norris CM, Posner MR, Goodson JM (2005) The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med 3: 27.
15. Merrell MA, Ilvesaro JM, Lehtonen N, Sorsa T, Gehrs B, Rosenthal E, Chen D, Shackley B, Harris KW, Selander KS (2006) Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol Cancer Res 4: 437-447.
16. Meurman JH (2010) Oral microbiota and cancer. J Oral Microbiol 2; doi: 10.3402/jom.v2i0.5195.
17. Moller H (1989) Changing incidence of cancer of the tongue, oral cavity, and pharynx in Denmark. J Oral Pathol Med 18: 224-229.
18. Oblak A, Jerala R (2011) Toll-like receptor 4 activation in cancer progression and therapy. Clin Dev Immunol 2011: 609579.
19. Park JH, Yoon HE, Jeon DI, Ahn SG, Yoon JH (2010) Activation of TLR2 and TLR5 did not affect tumor progression of an oral squamous cell carcinoma, YD-10B cells. J Oral Pathol Med 39: 781-785.
20. Park JH, Yoon HE, Kim DJ, Kim SA, Ahn SG, Yoon JH (2011a) Toll-like receptor 5 activation promotes migration and invasion of salivary gland adenocarcinoma. J Oral Pathol Med 40: 187-193.
21. Park WS, Ryu J, Cho KH, Choi MK, Moon SH, Yun T, Chun BS, Lee GK, Ahn HJ, Lee JH, Vermeer P, Jung YS (2011b) Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea: use of G1 cycle markers as new prognosticators. Head Neck 34: 1408-1417.
22. Pimentel-Nunes P, Afonso L, Lopes P, Roncon-Albuquerque Jr. R, Goncalves N, Henrique R, Moreira-Dias L, Leite-Moreira AF, Dinis-Ribeiro M (2011) Increased expression of toll-like receptors (TLR) 2, 4 and 5 in gastric dysplasia. Pathol Oncol Res 17: 677-683.
23. Pimentel-Nunes P, Goncalves N, Boal-Carvalho I, Afonso L, Lopes P, Roncon-Albuquerque Jr R, Henrique R, Moreira-Dias L, Leite-Moreira AF, Dinis-Ribeiro M (2012a) Helicobacter pylori Induces increased expression of toll-like receptors and decreased toll-interacting protein in gastric mucosa that persists throughout gastric carcinogenesis. Helicobacter doi: 10.1111/hel.12008.
24. Pimentel-Nunes P, Goncalves N, Boal-Carvalho I, Afonso L, Lopes P, Roncon-Albuquerque Jr R, Soares JB, Cardoso E, Henrique R, Moreira-Dias L, Dinis-Ribeiro M, Leite-Moreira AF (2012b) Decreased Toll-interacting protein and peroxisome proliferator-activated receptor gamma are associated with increased expression of Toll-like receptors in colon carcinogenesis. J Clin Pathol 65: 302-308.
25. Ren T, Wen ZK, Liu ZM, Liang YJ, Guo ZL, Xu L (2007) Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasis. Cancer Biol Ther 6: 1704-1709.
26. Rosenquist K, Wennerberg J, Schildt EB, Bladstrom A, Goran Hansson B, Andersson G (2005) Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden. Acta Otolaryngol 125: 1327-1336.
27. Rydberg C, Mansson A, Uddman R, Riesbeck K, Cardell LO (2009) Toll-like receptor agonists induce inflammation and cell death in a model of head and neck squamous cell carcinomas. Immunology 128: e600-e611.
28. Sano D, Myers JN (2007) Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 26: 645-662.
29. Schmausser B, Andrulis M, Endrich S, Muller-Hermelink HK, Eck M (2005) Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. Int J Med Microbiol 295: 179-185.
30. Song EJ, Kang MJ, Kim YS, Kim SM, Lee SE, Kim CH, Kim DJ, Park JH (2011) Flagellin promotes the proliferation of gastric cancer cells via the Toll-like receptor 5. Int J Mol Med 28: 115-119.
31. Takala H, Kauppila JH, Soini Y, Selander KS, Vuopala KS, Lehenkari PP, Saarnio J, Karttunen TJ (2011) Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression. J Innate Immun 3: 631-638.
32. Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21: 335-376.
33. Yang HZ, Cui B, Liu HZ, Mi S, Yan J, Yan HM, Hua F, Lin H, Cai WF, Xie WJ, Lv XX, Wang XX, Xin BM, Zhan QM, Hu ZW (2009) Blocking TLR2 activity attenuates pulmonary metastases of tumor. PLoS ONE 4: e6520.
34. Zeng HM, Pan KF, Zhang Y, Zhang L, Ma JL, Zhou T, Su HJ, Li WQ, Li JY, Gerhard M, Classen M, You WC (2011) Genetic variants of toll-like receptor 2 and 5, helicobacter pylori infection, and risk of gastric cancer and its precursors in a chinese population. Cancer Epidemiol Biomarkers Prev 20: 2594-2602.